| Company Name: |
ChemStrong Scientific Co.,Ltd
|
| Tel: |
0755-0755-66853366 13670046396 |
| Email: |
sales@chem-strong.com |
| Products Intro: |
Product Name:1a,1b-dihomo Prostaglandin E1
CAS:23452-98-4
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:1a,1b-dihomo Prostaglandin E1
CAS:23452-98-4
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:1a,1b-dihomo Prostaglandin E1
CAS:23452-98-4
Purity:98% Package:1mg;5mg;10mg
|
|
| | 1A,1B-DIHOMO PROSTAGLANDIN E1 Basic information |
| Product Name: | 1A,1B-DIHOMO PROSTAGLANDIN E1 | | Synonyms: | 9-OXO-11ALPHA,15S-DIHYDROXY-1A,1B-DIHOMO-PROST-13E-EN-1-OIC ACID;1A,1B-DIHOMO PROSTAGLANDIN E1;YMDDELUTDBQEMT-QZCLESEGSA-N;1a,1b-dihomo PGE1;9-oxo-11α,15S-dihydroxy-1a,1b-dihomo-prost-13E-en-1-oic acid;Cyclopentanenonanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, [1R-[1α,2β(1E,3S*),3α]]- (9CI) | | CAS: | 23452-98-4 | | MF: | C22H38O5 | | MW: | 382.53 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | 1A,1B-DIHOMO PROSTAGLANDIN E1 Chemical Properties |
| Boiling point | 550.1±50.0 °C(Predicted) | | density | 1.104±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: >100 mg/ml; DMSO: >50 mg/ml; Ethanol: >50 mg/ml; PBS pH 7.2: >1.6 mg/ml | | pka | 4.78±0.10(Predicted) |
| | 1A,1B-DIHOMO PROSTAGLANDIN E1 Usage And Synthesis |
| Description | Prostaglandin E1 (PGE1) is not a major naturally occurring PG, but is widely administered clinically for several indications including peripheral occlusive vascular disease, erectile dysfunction, and in neonatal cardiology.1,2 COX metabolism of the unusual fatty acid 10,13,16-docosatrienoic acid yields 1a,1b-dihomo PGE1. This rare metabolite has been recovered from incubations of whole sheep seminal vesicles, but has not been reported in humans.3 In ex vivo preparations of rat aorta and rat PRP, 1a,1b-dihomo PGE1 was found to be much less active than PGE1 itself.4 | | Definition | ChEBI: 1a,1b-dihomo-PGE1 is a prostanoid. | | References | 1. Virag, R., Shoukry, K., Floresco, J., et al. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-Year experience with 615 cases J. Urol. 145(2),287-293(1991).
2. Hoshi, K. Approved indications of lipo-PGE1 in Japan Adv. Drug Deliv. Rev. 20(2-3),171-176(1996).
3. Samel, N., and Maxey, K.M. Personal Communication ,(2003).
4. Kloeze, J. Relationship between chemical structure and platelet-aggregation activity of prostaglandins Biochim. Biophys. Acta 187(3),285-292(1969). |
| | 1A,1B-DIHOMO PROSTAGLANDIN E1 Preparation Products And Raw materials |
|